A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors
Trial Status: active
This is a Phase 1, first-in-human, open-label, multi-center study with the aim of exploring the safety, tolerability, PK, and preliminary anti-tumor activity of ANS014004 as a single agent in participants with locally advanced or metastatic solid tumors.